Quadrant Capital Group’s Acceleron Pharma Inc. XLRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q4 | – | Sell |
-37
| Closed | -$6K | – | 2790 |
|
2021
Q3 | $6K | Sell |
37
-8
| -18% | -$1.3K | ﹤0.01% | 1840 |
|
2021
Q2 | $6K | Sell |
45
-20
| -31% | -$2.67K | ﹤0.01% | 1810 |
|
2021
Q1 | $9K | Buy |
65
+39
| +150% | +$5.4K | ﹤0.01% | 1573 |
|
2020
Q4 | $3K | Buy |
26
+13
| +100% | +$1.5K | ﹤0.01% | 1900 |
|
2020
Q3 | $1K | Buy |
13
+5
| +63% | +$385 | ﹤0.01% | 2128 |
|
2020
Q2 | $1K | Hold |
8
| – | – | ﹤0.01% | 2182 |
|
2020
Q1 | $0 | Buy |
8
+5
| +167% | – | ﹤0.01% | 2341 |
|
2019
Q4 | $0 | Buy |
+3
| New | – | ﹤0.01% | 2527 |
|
2019
Q2 | – | Sell |
-1,008
| Closed | -$46K | – | 2437 |
|
2019
Q1 | $46K | Buy |
+1,008
| New | +$46K | 0.01% | 1274 |
|